This $400 Million Pot Stock Can Go to $2 Billion

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the most popular brands in Canada. Its market cap exceeds $10 billion, giving it plenty of liquidity to pursue long-term growth opportunities. If you look closely, it’s clear that Molson is about to send shares of one pot stock soaring. It’s important to note that Molson hasn’t entered the marijuana industry directly.…

Read More

Canopy (TSX:WEED) and Aurora (TSX:ACB): Two Industry Juggernauts With Very Different Strategies

As the Canadian cannabis space has begun to enter a new phase, it is interesting to look back at how we got here. An initial frantic arms race to accumulate as much production capacity as possible eventually gave way to the reality that demand would be a lot slower to migrate to the legal market than market participants had hoped.…

Read More

Buy Alert: Molson Coors (TSX:TPX.B) Might Buy This Pot Stock

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is a Canadian icon.  Last year, it generated more than $10 billion in sales. But there’s a problem: growth has stagnated. Last quarter, revenue declined by 8.7% year over year. “After a corporate restructuring in the fourth quarter of 2019 and a bevy of new products hitting the market in the New Year, Molson Coors…

Read More

Should You Buy Canopy Growth (TSX:WEED) or Aurora Cannabis (TSX:ACB) Stock?

Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…

Read More

HEXO Finds a New Market: Should Cannabis Investors Celebrate?

Cannabis producer HEXO (TSX:HEXO)(NYSE:HEXO) announced its first-ever product export to Israel on Thursday. The company has finally found a new market for medical marijuana after several quarters of declining segment sales. A recovering HEXO stock surged more than 5% on the news as investors took notice. However, should the market celebrate this latest win? What happened? HEXO has entered a 24-month…

Read More

Big Tobacco Is Betting $2 Billion on This Pot Stock

Altria Group (NYSE:MO) is one of the largest tobacco producers in the world. Its size is truly remarkable. Last quarter, despite the onset of the COVID-19 pandemic, the company generated more than $5 billion in sales. It also produced a quarterly profit of nearly $2 billion, up 38% year over year. Those profits help service an 8.6% dividend. If you…

Read More

Canopy Growth (TSX:WEED) Stock: $0 or $100?

Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…

Read More

My Top Cannabis Pick

This recent market turmoil has resulted in what I can only describe as a tectonic shift in the Canadian cannabis sector. Investors have moved from a growth-at-any-cost, risk-seeking base of retail investors to a much more conservative, long-term group of investors. Stock prices tell this story. In this article, I’m going to discuss why, despite more downside likely on the…

Read More

What Should Investors Expect From Canopy Growth (TSX:WEED) Stock?

Cannabis investors punished Canopy Growth (TSX:WEED)(NYSE:CGC) after a worse-than-expected earnings report revealing deep cracks in the industry. Canopy plunged as a result. For once, though, the drop looks less like a value opportunity than a wake-up call. But what’s the outlook for this cannabis stock, and why are investors so divided on its outlook? Let’s take a look. Is Canopy…

Read More

What Aphria’s Move From the NYSE to the NASDAQ Means for Stock Investors

In an unexpected move on Tuesday, one of Canada’s largest marijuana firms Aphria (TSX:APHA)(NYSE:APHA) announced that it is moving its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market effective on Monday, June 8. Aphria’s stock listing migration will take place soon after the firm closes its fiscal year 2020 financial books on…

Read More